We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




PACSHealth and SWEDUS form Partnership to Market Radiation Monitoring Software

By MedImaging International staff writers
Posted on 19 Oct 2010
PACSHealth joined SWEDUS, LLC, a U.S. based unit of Sapheneia, to form PHS Technologies Group (PHSTG). The new company is the developer and marketer of DoseMonitor, software that monitors the calculated cumulative radiation dose received during ionizing radiation procedures. DoseMonitor answers the call for radiation dose tracking by regulatory agencies following reported cases of overexposure to radiation from diagnostic imaging procedures.

Using mathematical algorithms and the standardized dose values of diagnostic imaging equipment, DoseMonitor calculates a patient's historical radiation exposure and provides a customer-defined "red/yellow/green” type alerts. In addition, by using dose values from imaging equipment, devices and procedures that no longer meet safe dosage specifications can be identified.

DoseMonitor will be introduced at the upcoming meeting of the Radiological Society of North America (RSNA) during November 28 – December 3, 2010 in Chicago (IL, USA).

Sapheneia, AB (Stockholm, Sweden) is an imaging services company, which provides products and applications development services globally, specializing in diagnostic and analytical image processing product solutions for medical and scientific imaging.

PACSHealth, LLC (Scottsdale, AZ, USA) is a software development company specializing in systems for medical imaging.

Related Links:
Sapheneia
PACSHealth


Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
X-Ray Illuminator
X-Ray Viewbox Illuminators
Digital X-Ray Detector Panel
Acuity G4
High-Precision QA Tool
DEXA Phantom

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.